These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38220121)

  • 1. Molecular interactions of hydrated co-amorphous systems of prilocaine and lidocaine.
    Xu X; Rades T; Grohganz H
    Int J Pharm; 2024 Feb; 651():123807. PubMed ID: 38220121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Water on Amorphous Lidocaine.
    Xu X; Grohganz H; Rades T
    Mol Pharm; 2022 Sep; 19(9):3199-3205. PubMed ID: 35876141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal investigation on hydrated co-amorphous systems of nicotinamide and prilocaine.
    Xu X; Rades T; Grohganz H
    Eur J Pharm Biopharm; 2023 May; 186():1-6. PubMed ID: 36878408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-plasticizing effect of water on prilocaine and lidocaine - the role of the hydrogen bonding pattern.
    Xu X; Grohganz H; Rades T
    Phys Chem Chem Phys; 2024 May; 26(19):14149-14159. PubMed ID: 38712380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stability.
    Hu D; Chen X; Li D; Zhang H; Duan Y; Huang Y
    Int J Pharm; 2023 Mar; 635():122707. PubMed ID: 36764418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-amorphous Systems of Sinomenine with Platensimycin or Sulfasalazine: Physical Stability and Excipient-Adjusted Release Behavior.
    Chen X; Li D; Zhang H; Duan Y; Huang Y
    Mol Pharm; 2022 Nov; 19(11):4370-4381. PubMed ID: 36251509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guest:host interactions of lidocaine and prilocaine with natural cyclodextrins: spectral and molecular modeling studies.
    Rajendiran N; Mohandoss T; Saravanan J
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():387-96. PubMed ID: 24887500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study.
    Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C
    Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The development of co-amorphous drug systems].
    Yao J; Shi NQ; Wang XL
    Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multivariate Approach for the Determination of the Optimal Mixing Ratio of the Non-Strong Interacting Co-Amorphous System Carvedilol-Tryptophan.
    Di R; Liu J; Grohganz H; Rades T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33557164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuning molecular dynamics by hydration and confinement: antiplasticizing effect of water in hydrated prilocaine nanoclusters.
    Ruiz GN; Combarro-Palacios I; McLain SE; Schwartz GA; Pardo LC; Cerveny S; Macovez R
    Phys Chem Chem Phys; 2019 Jul; 21(28):15576-15583. PubMed ID: 31267115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.
    Huang Y; Zhang Q; Wang JR; Lin KL; Mei X
    Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of co-amorphous carvedilol-maleic acid system prepared by solvent evaporation.
    Furuishi T; Sato-Hata N; Fukuzawa K; Yonemochi E
    Pharm Dev Technol; 2023; 28(3-4):309-317. PubMed ID: 36946594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
    Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
    J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of variation in molar ratio on co-amorphous drug-amino acid systems.
    Jensen KT; Larsen FH; Löbmann K; Rades T; Grohganz H
    Eur J Pharm Biopharm; 2016 Oct; 107():32-9. PubMed ID: 27368747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting different amorphous - Amorphous phase separation patterns in co-amorphous mixtures with high resolution imaging FTIR spectroscopy.
    Kilpeläinen T; Ervasti T; Uurasjärvi E; Koistinen A; Ketolainen J; Korhonen O; Pajula K
    Eur J Pharm Biopharm; 2022 Nov; 180():161-169. PubMed ID: 36122786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural, thermal, vibrational, solubility and DFT studies of a tolbutamide co-amorphous drug delivery system for treatment of diabetes.
    R Sá M; Sarraguça JMG; de Sousa FF; Sarraguça MSC; Lopes JA; Lima ADDSG; Lage MR; Ribeiro PRS
    Int J Pharm; 2022 Mar; 615():121500. PubMed ID: 35077862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-amorphous systems of sinomenine with nonsteroidal anti-inflammatory drugs: A strategy for solubility improvement, sustained release, and drug combination therapy against rheumatoid arthritis.
    Chen X; Li D; Zhang H; Duan Y; Huang Y
    Int J Pharm; 2021 Sep; 606():120894. PubMed ID: 34280485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.